CKD-EPI 2012 Cystatin C
Chronic Kidney Disease Epidemiology Collaboration
Cystatin C–only equation for adults, with no race coefficient
- Biomarkers
- Cystatin C
- Validated for
- 18+ years
- Inputs
- Age, Sex, Cystatin C
- Reports
- mL/min/1.73 m²
- Published
- 2012
The eGFR guide explains which equation the calculator suggests and indexed and absolute GFR.
Formula
As text: eGFR = 133 × min(SCys/0.8,1)^(-0.499) × max(SCys/0.8,1)^(-1.328) × 0.9962^Age × (0.932 if female)
Constants
| Symbol | Meaning | Value |
|---|---|---|
133 | Base coefficient | |
0.8 | Cystatin C reference value | mg/L |
−0.499 | Exponent when SCys/0.8 < 1 | |
−1.328 | Exponent when SCys/0.8 ≥ 1 | |
0.9962 | Age decay factor — full-precision coefficient from Inker 2021 Table 2 (printed as 0.996 in the 2012 paper) | per year |
Sex factor | Sex-dependent multiplier | Female: 0.932 Male: 1.000 |
SCys | Serum cystatin C (input) | mg/L |
Age | Patient age (input) | years |
How it was developed
Developed by the CKD-EPI collaboration in 5,352 participants from 13 studies, with GFR measured as urinary iothalamate clearance. It was validated externally in 1,119 participants from 5 other studies that measured GFR with other filtration markers.
Clinical notes
- Built on cystatin C traceable to IFCC/IRMM reference material (ERM-DA471)
- Carried into CKD-EPI 2021 unchanged as the current cystatin C equation
- Cystatin C is less affected by muscle mass and diet than creatinine
Limitations
- Not developed or validated in transplant recipients
- No development data from people with markedly reduced muscle mass or malnutrition
- Cystatin C may be affected by adiposity, smoking, thyroid dysfunction, glucocorticoids, inflammation
References
- Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29. doi:10.1056/NEJMoa1114248
- Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018